InsideTrading SEC Form 4 insider trades

Stocks

PMVP PMV Pharmaceuticals, Inc.

Healthcare · Market cap: $67.9M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $10.3M 2022-Q2: bought $0, sold $418.2K 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $68.8K 2023-Q4: bought $0, sold $195.8K 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $0 2024-Q3: bought $0, sold $15.2K 2024-Q4: bought $0, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $1.1M 2025-Q4: bought $0, sold $1.5M 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $0, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $0) Sold, below the line (largest quarter $10.3M)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$10.3M
2022-Q2$0$418.2K
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$68.8K
2023-Q4$0$195.8K
2024-Q1$0$0
2024-Q2$0$0
2024-Q3$0$15.2K
2024-Q4$0$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$1.1M
2025-Q4$0$1.5M
2026-Q1$0$0
2026-Q2$0$0
2026-Q3$0$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$00 buy days
Sold$13.5M15 sell days
Net insider flow-$13.5Mnet selling · 5 years
Latest trade2025-10-23ORBIMED ADVISORS LLC
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2025-10-23 Sell ORBIMED ADVISORS LLC 10% owner 1,000,000 $1.52 $1.5M 1
2025-09-10 Sell ORBIMED ADVISORS LLC 10% owner 500,000 $1.80 $900.0K 1
2025-07-01 Sell Mack David Henry CEO 58,411 $1.06 $61.9K 1
2025-07-01 Sell Jalota Deepika Other C-suite 33,065 $1.06 $35.0K 1
2025-07-01 Sell Carulli Michael CFO 28,249 $1.06 $29.9K 1
2025-07-01 Sell Ticktin Robert COO 23,151 $1.06 $24.5K 1
2024-09-11 Sell Jalota Deepika Other C-suite 7,218 $1.50 $10.8K 1
2024-09-11 Sell Carulli Michael CFO 2,891 $1.50 $4.3K 1
2023-11-22 Sell ORBIMED ADVISORS LLC 10% owner 87,786 $2.23 $195.8K 1
2023-09-15 Sell Alland Leila Other C-suite 6,291 $6.62 $41.6K 1
2023-09-15 Sell Jalota Deepika Other C-suite 4,104 $6.62 $27.2K 1
2022-05-26 Sell ORBIMED ADVISORS LLC 10% owner 26,253 $15.93 $418.2K 1
2022-03-31 Sell ORBIMED ADVISORS LLC 10% owner 34,500 $21.17 $730.4K 1
2022-03-30 Sell ORBIMED ADVISORS LLC 10% owner 75,000 $22.39 $1.7M 1
2022-03-29 Sell ORBIMED ADVISORS LLC 10% owner 365,000 $21.52 $7.9M 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
ORBIMED ADVISORS LLC 10% owner $0 $13.3M 2025-10-23
Jalota Deepika Other C-suite $0 $73.0K 2025-07-01
Mack David Henry CEO $0 $61.9K 2025-07-01
Alland Leila Other C-suite $0 $41.6K 2023-09-15
Carulli Michael CFO $0 $34.3K 2025-07-01
Ticktin Robert COO $0 $24.5K 2025-07-01

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

Buying clusters at this company, newest first, with the return against the benchmark that followed
Window Insiders Total Score 21 days vs benchmark63 days vs benchmark126 days vs benchmark Status
2020-09-25 → 2020-09-29 6 $55.3M 50 -7.0% (-7.9% raw)+36.2% (+48.3% raw)-34.6% (-13.4% raw) closed

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.